TickerFactsScreenerDevelopers

AIM ImmunoTech Inc. (AIM) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$9.30M2010: -$11.89M2011: -$10.10M2012: -$13.14M2013: -$16.83M2014: -$13.96M2015: -$16.05M2016: -$7.38M2017: -$7.94M2018: -$10.64M2019: -$9.07M2020: -$10.37M2021: -$13.96M2022: -$16.11M2023: -$21.27M2024: -$14.89M2025: -$10.96M-$10.96M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$10.96M+26.4%
2024-$14.89M+30.0%
2023-$21.27M-32.0%
2022-$16.11M-15.3%
2021-$13.96M-34.7%
2020-$10.37M-14.3%
2019-$9.07M+14.8%
2018-$10.64M-34.0%
2017-$7.94M-7.6%
2016-$7.38M+54.0%
2015-$16.05M-15.0%
2014-$13.96M+17.0%
2013-$16.83M-28.1%
2012-$13.14M-30.1%
2011-$10.10M+15.1%
2010-$11.89M-27.8%
2009-$9.30M—